Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08217 vs PWR, FIX, EME: Days Payable Comparison
For the Engineering & Construction subindustry, Ju Fu Tang Biotech Holdings Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ju Fu Tang Biotech Holdings Co Days Payable vs Construction Industry
For the Construction industry and Industrials sector, Ju Fu Tang Biotech Holdings Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Ju Fu Tang Biotech Holdings Co's Days Payable falls into.
Ju Fu Tang Biotech Holdings Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ju Fu Tang Biotech Holdings Co (HKSE:08217) has a Days Payable of 206.87 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. This is 228% above median its historical median of 63.01. Over the past decade, Ju Fu Tang Biotech Holdings Co's Days Payable has ranged from 24.99 to 277.22. According to the industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #260 out of 1719 companies in the Construction industry, placing it in the top 15.1%.
Is Ju Fu Tang Biotech Holdings Co's Days Payable too high?
Ju Fu Tang Biotech Holdings Co's current Days Payable of 206.87 is 228% above median its 10-year median of 63.01. Over the past 10 years, this metric has ranged from a low of 24.99 to a high of 277.22. The Construction industry median Days Payable is 76.33. Ju Fu Tang Biotech Holdings Co's value of 206.87 is 171% above this industry median. Based on the distribution chart, Ju Fu Tang Biotech Holdings Co ranks #260 out of 1719 companies in the Construction industry, which is in the top quartile — a strong position relative to peers. Overall, Ju Fu Tang Biotech Holdings Co has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ju Fu Tang Biotech Holdings Co's Days Payable compare to PWR and FIX?
According to the Construction industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #260 out of 1719 companies for Days Payable. This places Ju Fu Tang Biotech Holdings Co in the top 15% of its industry — outperforming the majority of peers. The industry median Days Payable is 76.33. Ju Fu Tang Biotech Holdings Co's value of 206.87 is 171% above this benchmark. Historically, Ju Fu Tang Biotech Holdings Co's own Days Payable has ranged from 24.99 to 277.22 over the past decade. While the company's 10-year median is 63.01 vs. the industry median of 76.33, Ju Fu Tang Biotech Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Construction company?
The median Days Payable among Construction companies is 76.33, based on 1,719 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ju Fu Tang Biotech Holdings Co's current Days Payable of 206.87 is 171% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. For the Construction industry, the median Days Payable is 76.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ju Fu Tang Biotech Holdings Co's current Days Payable is 206.87, which is 228% above median its own 10-year median of 63.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ju Fu Tang Biotech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co (HKSE:08217) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.11 — trading 26% below its estimated fair value. The current Days Payable is 206.87, which is 228% above median its 10-year median of 63.01 and 171% above the Construction industry median of 76.33. Ju Fu Tang Biotech Holdings Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ju Fu Tang Biotech Holdings Co (HKSE:08217), the current Days Payable is 206.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ju Fu Tang Biotech Holdings Co (HKSE:08217) Overvalued in 2026?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co stock appears to be undervalued.
The current stock price of HK$0.11 is trading 26% below its estimated GF Value™ of HK$0.15.
GuruFocus considers Ju Fu Tang Biotech Holdings Co to be Modestly Undervalued.
Key valuation signals for HKSE:08217:
Days Payable: 206.87 (228% above median its 10-year median of 63.01)
GF Value™: HK$0.15 vs. price of HK$0.11 (26% below fair value)
Industry Position: 171% above the Construction median (#260 of 1719)
No single metric tells the full story. See the HKSE:08217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ju Fu Tang Biotech Holdings Co Ltd, formerly known as WMHW Holdings Ltd, is an investment holding company operating through its subsidiaries. It engaged in the provision of construction works and investment holding.
36GF Score
Get the complete analysis for HKSE:08217
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08217 has been successfully added to your 
